Myriad Genetics, Inc’s filing revealed that its President and CEO DIAZ PAUL J unloaded Company’s shares for reported $0.34 million on Oct 11 ’24. In the deal valued at $22.93 per share,15,000 shares were sold. As a result of this transaction, DIAZ PAUL J now holds 962,378 shares worth roughly $16.66 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DIAZ PAUL J bought 15,000 shares, generating $343,950 in total proceeds.
Before that, Ancona Margaret bought 11,538 shares. Myriad Genetics, Inc shares valued at $321,019 were divested by the Officer at a price of $27.82 per share.
Morgan Stanley initiated its Myriad Genetics, Inc [MYGN] rating to an Equal-weight in a research note published on September 19, 2024; the price target was $32. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late August with a ‘”an Overweight”‘ rating. Scotiabank began covering MYGN with “Sector outperform” recommendation on June 27, 2024.
Price Performance Review of MYGN
On Monday, Myriad Genetics, Inc [NASDAQ:MYGN] saw its stock fall -0.57% to $17.31. Over the last five days, the stock has lost -2.92%. Myriad Genetics, Inc shares have fallen nearly -9.56% since the year began. Nevertheless, the stocks have risen 6.26% over the past one year. While a 52-week high of $29.30 was reached on 09/18/24, a 52-week low of $15.99 was recorded on 11/01/24. SMA at 50 days reached $24.32, while 200 days put it at $23.72.
Levels Of Support And Resistance For MYGN Stock
The 24-hour chart illustrates a support level at 17.01, which if violated will result in even more drops to 16.71. On the upside, there is a resistance level at 17.72. A further resistance level may holdings at 18.13. The Relative Strength Index (RSI) on the 14-day chart is 21.26, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.40, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.68%. Stochastics %K at 9.58% indicates the stock is a buying.
How much short interest is there in Myriad Genetics, Inc?
A steep rise in short interest was recorded in Myriad Genetics, Inc stocks on 2024-10-15, growing by 0.56 million shares to a total of 4.49 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 3.94 million shares. There was a rise of 12.35%, which implies that there is a positive sentiment for the stock.
